Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Goldkorn

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Expert Review of Anticancer Therapy|September 10, 2014
Circulating tumor cells in prostate cancer: a better predictor of survival than prostate specific antigen?Brian Hu, Amir Goldkorn
Cancer Treatment and Research|September 1, 2018
Liquid Biopsy in Prostate Cancer: Circulating Tumor Cells and BeyondDaniel Zainfeld, Amir Goldkorn
Genes|May 31, 2016
Telomere and Telomerase Therapeutics in CancerYucheng Xu, Amir Goldkorn
Current Oncology Reports|March 25, 2018
Development and Application of Liquid Biopsies in Metastatic Prostate CancerGareth J Morrison, Amir Goldkorn
Cancer Research|June 3, 2006
Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cellsAmir Goldkorn, Elizabeth H Blackburn
Cancers|December 6, 2013
Circulating tumor cells in prostate cancerBrian Hu, Holly Rochefort, Amir Goldkorn
Molecular Cancer Therapeutics|April 27, 2011
Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotypeKaijie He, Tong Xu, Amir Goldkorn
Clinical Advances in Hematology & Oncology : H&O|August 16, 2011
Telomerase targeted therapy in cancer and cancer stem cellsYucheng Xu, Kaijie He, Amir Goldkorn
Therapeutic Advances in Medical Oncology|July 27, 2011
Targeted therapy in renal cancerTanya B Dorff, Amir Goldkorn, David I Quinn
Frontiers in Oncology|February 14, 2017
Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision MedicineCory M Hugen, Daniel E Zainfeld, Amir Goldkorn
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Expert Review of Anticancer Therapy|September 10, 2014
Circulating tumor cells in prostate cancer: a better predictor of survival than prostate specific antigen?Brian Hu, Amir Goldkorn
Cancer Treatment and Research|September 1, 2018
Liquid Biopsy in Prostate Cancer: Circulating Tumor Cells and BeyondDaniel Zainfeld, Amir Goldkorn
Genes|May 31, 2016
Telomere and Telomerase Therapeutics in CancerYucheng Xu, Amir Goldkorn
Current Oncology Reports|March 25, 2018
Development and Application of Liquid Biopsies in Metastatic Prostate CancerGareth J Morrison, Amir Goldkorn
Cancer Research|June 3, 2006
Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cellsAmir Goldkorn, Elizabeth H Blackburn
Cancers|December 6, 2013
Circulating tumor cells in prostate cancerBrian Hu, Holly Rochefort, Amir Goldkorn
Molecular Cancer Therapeutics|April 27, 2011
Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotypeKaijie He, Tong Xu, Amir Goldkorn
Clinical Advances in Hematology & Oncology : H&O|August 16, 2011
Telomerase targeted therapy in cancer and cancer stem cellsYucheng Xu, Kaijie He, Amir Goldkorn
Therapeutic Advances in Medical Oncology|July 27, 2011
Targeted therapy in renal cancerTanya B Dorff, Amir Goldkorn, David I Quinn
Frontiers in Oncology|February 14, 2017
Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision MedicineCory M Hugen, Daniel E Zainfeld, Amir Goldkorn
Pageof 5